Kura Oncology COO Kathleen Ford sells $111,930 in company stock

Chief Operating Officer Kathleen Ford of Kura Oncology Inc. (NASDAQ: KURA) recently divested shares of the company's common stock, amounting to $111,930. The sale took place over two days, with the stock price fluctuating between $10.50 and $10.87 per share. On September 28, 2026, Ms. Ford divested 6,906 shares, receiving $72,494 at a price of $10.4973 per share.

Despite a 2.1% decrease in stock value over the past week, the shares currently trade at $10.81, having experienced a 32.9% gain over the past six months. This transaction was primarily to cover taxes related to the vesting of performance-based restricted stock units (PSUs) granted to Ms. Ford on May 31, 2023. These PSUs granted Ms. Ford the right to receive shares contingent on specified development milestones and continuous service.

Upon the vesting on September 27, 2026, she sold an additional 3,668 shares on September 29, 2026, for a total of $39,436. This sale was executed in accordance with a Rule 10b5-1 trading plan adopted on May 29, 2026. Consequently, Ms. Ford now holds a total of 142,986 shares of Kura Oncology common stock directly. Analysts suggest the stock may be slightly overvalued compared to its estimated Fair Value.

Kura Oncology recently reported impressive Q2 2026 results, surpassing Wall Street expectations with an adjusted loss of $0.77 per share and revenue of $20.87 million. President and CEO Troy Edward Wilson also made a significant insider purchase of 100,000 shares at prices ranging from $10.87 to $12.85 per share. Investors are encouraged to consult InvestingPro for a comprehensive analysis, Pro Research Report, and additional ProTips for deeper insights into Kura Oncology.